GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (STU:73R) » Definitions » 3-Year FCF Growth Rate

Apollon Formularies (STU:73R) 3-Year FCF Growth Rate : 37.90% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Apollon Formularies 3-Year FCF Growth Rate?

Apollon Formularies's Free Cash Flow per Share for the six months ended in Jun. 2023 was €0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 37.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 11 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Apollon Formularies was 37.90% per year. The lowest was 37.90% per year. And the median was 37.90% per year.


Competitive Comparison of Apollon Formularies's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollon Formularies's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's 3-Year FCF Growth Rate falls into.



Apollon Formularies 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Apollon Formularies  (STU:73R) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Apollon Formularies 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Apollon Formularies (STU:73R) Business Description

Comparable Companies
Traded in Other Exchanges
Address
6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS
Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.

Apollon Formularies (STU:73R) Headlines

No Headlines